General MedicationsORALStandard
DICLOXACILLIN SODIUM
DICLOXACILLIN SODIUM
Standard Dose
EQ 250MG BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview DICLOXACILLIN SODIUM is listed in Drugs@FDA under application 216845 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient DICLOXACILLIN SODIUM Form and strength CAPSULE;ORAL - EQ 250MG BASE Sponsor AUROBINDO PHARMA Submission history Latest submission status date: 2022-09-23 00:00:00.
Structured Monograph
Clinical summary
Approval overview DICLOXACILLIN SODIUM is listed in Drugs@FDA under application 216845 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient DICLOXACILLIN SODIUM Form and strength CAPSULE;ORAL - EQ 250MG BASE Sponsor AUROBINDO PHARMA Submission history Latest submission status date: 2022-09-23 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.